Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The effect of bradykinin (BK) on proteinase activity, prostaglandin synthesis, and the production of interleukin-6 (IL-6) was investigated in cultures of human osteoblast-like cells. Bradykinin had no effect on stromelysin activity and plasminogen activator activity produced by human osteoblast-like cells. However, BK stimulated the production of prostaglandin E2, an effect that was markedly enhanced by pre-incubation with recombinant interleukin-1 alpha (rhIL-1 alpha), but was apparently unaffected by BK receptor antagonists types 1 and 2. Bradykinin stimulated the intracellular accumulation of total inositol phosphates suggesting that its effects were mediated by stimulation of phosphoinositide metabolism. Bradykinin within the dose range of 10(-11)-10(-5) M also significantly stimulated the production of IL-6. Bradykinin may, therefore, mediate a variety of responses in bone under both physiological and pathological conditions.

Original publication

DOI

10.1016/0167-4889(92)90172-8

Type

Journal article

Journal

Biochim biophys acta

Publication Date

30/04/1992

Volume

1135

Pages

97 - 102

Keywords

Bradykinin, Cells, Cultured, Dinoprostone, Dose-Response Relationship, Drug, Enzyme-Linked Immunosorbent Assay, Humans, Inositol Phosphates, Interleukin-6, Kinetics, Matrix Metalloproteinase 3, Metalloendopeptidases, Osteoblasts, Signal Transduction